Literature DB >> 1373342

Anti-(human LFA-1) monoclonal antibodies bind P815 murine tumour cells.

M J Palisson1, A Altemeyer, I Moosbrugger, S Warter, G Hauptmann, P Bischoff.   

Abstract

Using anti-CD11a and anti-CD18 monoclonal antibodies (mAbs) directed respectively against the alpha and the beta chains of LFA-1, we obtained an important and specific staining of P815 murine tumour cells. Both ascitic and cultured cells displayed a positive staining. Other murine tumours of haematopoietic origin, as well as lymphocytes or lymphoblasts from DBA/2 mice, were not labelled by the same monoclonal antibodies. These results were surprising since, to our knowledge, no case of cross-reaction between species has been reported with LFA-1. Moreover, competition assays showed that epitopes recognized by the two anti-CD11a antibodies were different from those identified by H35.89.9, a mAb raised against the murine LFA-1 alpha chain. Using allogeneic cytotoxic T lymphocytes, we also showed that anti-(human LFA-1) mAbs were unable to block the lysis of P815 by these effector cells. Thus, the putative functional properties of these structures, as well as their importance from an antigeneic point of view, remain to be assessed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373342     DOI: 10.1007/bf01741752

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  35 in total

1.  Altered expression of lymphocyte functional antigen in Down syndrome.

Authors:  G M Taylor
Journal:  Immunol Today       Date:  1987

2.  A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells.

Authors:  C Morimoto; C E Rudd; N L Letvin; S F Schlossman
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

3.  Origin and partial characterization of Fc receptor-bearing cells found within experimental carcinomas and sarcomas.

Authors:  R S Kerbel; H F Pross; E V Elliott
Journal:  Int J Cancer       Date:  1975-06-15       Impact factor: 7.396

4.  Evidence for involvement of lymphocyte function-associated antigen 1 in T cell migration to epidermis.

Authors:  T Shiohara; N Moriya; K Saizawa; C Gotoh; H Yagita; M Nagashima
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

5.  Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells.

Authors:  K A Ault; T A Springer
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

6.  Heritable lymphocyte function-associated antigen-1 deficiency: abnormalities of cytotoxicity and proliferation associated with abnormal expression of LFA-1.

Authors:  A M Krensky; S J Mentzer; C Clayberger; D C Anderson; F C Schmalstieg; S J Burakoff; T A Springer
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

7.  Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.

Authors:  F Sanchez-Madrid; A M Krensky; C F Ware; E Robbins; J L Strominger; S J Burakoff; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  The Ly-15 alloantigenic system: a genetically determined polymorphism of the murine lymphocyte function-associated antigen-1 molecule.

Authors:  P M Hogarth; I D Walker; I F McKenzie; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

9.  In vitro modulation of leucocyte-function-associated antigen-1 expression on two leukemic cell lines.

Authors:  A Altmeyer; C Moog; C Waltzinger; G Hauptmann; P Bischoff
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

10.  Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.

Authors:  C Uyttenhove; J Maryanski; T Boon
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.